Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Sep-24 4:15 PM View:  | Manning Paul B Director 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 19-Sep-24 | Gift | 2,675,610 | -- | -- | 19% 13.81M to 16.48M | |
| 23-Sep-24 4:15 PM View: | Manning Paul B Director 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 19-Sep-24 | Gift | 2,675,610 | -- | -- | (16%) 16.48M to 13.81M | |
| 28-Aug-24 4:15 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 27-Aug-24 | Sale | 9,530 | $2.46 | $23,443.80 | (8%) 115.3K to 105.77K | |
| 28-Aug-24 4:15 PM View: | Kohler Terry Chief Financial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 27-Aug-24 | Sale | 7,899 | $2.46 | $19,431.50 | (15%) 52.6K to 44.7K | |
| 28-Aug-24 4:15 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 27-Aug-24 | Sale | 9,021 | $2.46 | $22,191.70 | (4%) 224.99K to 215.97K | |
| 28-Aug-24 4:15 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 27-Aug-24 | Sale | 8,993 | $2.46 | $22,122.80 | (11%) 82.11K to 73.11K | |
| 28-Aug-24 4:15 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 27-Aug-24 | Sale | 3,601 | $2.46 | $8,858.46 | (4%) 97.86K to 94.26K | |
| 28-Aug-24 4:15 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 26-Aug-24 | Sale | 26,183 | $2.66 | $69,646.80 | (19%) 141.49K to 115.3K | |
| 28-Aug-24 4:15 PM View: | Kohler Terry Chief Financial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 26-Aug-24 | Sale | 21,820 | $2.66 | $58,041.20 | (29%) 74.42K to 52.6K | |
| 28-Aug-24 4:15 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 26-Aug-24 | Sale | 24,979 | $2.66 | $66,444.10 | (10%) 249.97K to 224.99K | |
| 28-Aug-24 4:15 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 26-Aug-24 | Sale | 24,709 | $2.66 | $65,725.90 | (23%) 106.82K to 82.11K | |
| 28-Aug-24 4:15 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 26-Aug-24 | Sale | 9,888 | $2.66 | $26,302.10 | (9%) 107.75K to 97.86K | |
| 23-Jul-24 6:11 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 23-Jul-24 | Sale | 86 | $6.98 | $600.28 | (< 1%) 107.84K to 107.75K | |
| 23-Jul-24 6:10 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 23-Jul-24 | Sale | 91 | $6.98 | $635.18 | (< 1%) 141.58K to 141.49K | |
| 23-Jul-24 6:13 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 23-Jul-24 | Sale | 154 | $6.98 | $1,074.92 | (< 1%) 250.12K to 249.97K | |
| 23-Jul-24 6:12 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 23-Jul-24 | Sale | 115 | $6.98 | $802.70 | (< 1%) 106.93K to 106.82K | |
| 23-Jul-24 6:10 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 22-Jul-24 | Sale | 21,649 | $7.06 | $152,842.00 | (13%) 163.23K to 141.58K | |
| 23-Jul-24 6:13 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 22-Jul-24 | Sale | 32,469 | $7.06 | $229,231.00 | (11%) 282.59K to 250.12K | |
| 23-Jul-24 6:12 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 22-Jul-24 | Sale | 25,461 | $7.06 | $179,755.00 | (19%) 132.39K to 106.93K | |
| 23-Jul-24 6:11 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 22-Jul-24 | Sale | 18,421 | $7.06 | $130,052.00 | (15%) 126.26K to 107.84K | |
| 19-Mar-24 4:31 PM View: | Kohler Terry Chief Financial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Mar-24 | Grant | 40,000 | -- | -- | 116% 34.42K to 74.42K | |
| 19-Mar-24 4:31 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Mar-24 | Grant | 40,000 | -- | -- | 32% 123.23K to 163.23K | |
| 19-Mar-24 4:31 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 15-Mar-24 | Grant | 112,500 | -- | -- | 66% 170.09K to 282.59K | |
| 19-Mar-24 4:31 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Mar-24 | Grant | 40,000 | -- | -- | 43% 92.39K to 132.39K | |
| 19-Mar-24 4:31 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Mar-24 | Grant | 40,000 | -- | -- | 46% 86.26K to 126.26K | |
| 29-Dec-23 5:27 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 29-Dec-23 | Purchase | 115,774 | $7.24 | $838,204.00 | 2% 6.98M to 7.1M | |
| 29-Dec-23 5:27 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 28-Dec-23 | Purchase | 126,116 | $7.08 | $892,901.00 | 2% 6.86M to 6.98M | |
| 29-Dec-23 5:27 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 27-Dec-23 | Private Purchase | 79,726 | $7.20 | $574,027.00 | 1% 6.78M to 6.86M | |
| 26-Dec-23 7:21 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 26-Dec-23 | Purchase | 54,652 | $6.49 | $354,691.00 | < 1% 6.72M to 6.78M | |
| 26-Dec-23 7:21 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 22-Dec-23 | Purchase | 250,000 | $6.67 | $1,667,500.00 | 4% 6.47M to 6.72M | |
| 26-Dec-23 7:21 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 21-Dec-23 | Private Purchase | 200,000 | $6.17 | $1,234,000.00 | 3% 6.27M to 6.47M | |
| 19-Dec-23 5:52 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 19-Dec-23 | Purchase | 277,008 | $5.36 | $1,484,760.00 | 5% 6.0M to 6.27M | |
| 19-Dec-23 5:52 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 18-Dec-23 | Purchase | 456,923 | $5.41 | $2,471,950.00 | 8% 5.54M to 6.0M | |
| 19-Dec-23 5:52 PM View: | Perceptive Advisors LLC 10% Owner | Verrica Pharmaceuticals Inc. (VRCA) | 15-Dec-23 | Private Purchase | 500,000 | $5.97 | $2,985,000.00 | 10% 5.04M to 5.54M | |
| 16-Nov-23 4:33 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 15-Nov-23 | Sale | 11,558 | $2.97 | $34,327.30 | (6%) 181.65K to 170.09K | |
| 16-Nov-23 4:49 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Nov-23 | Sale | 11,266 | $2.97 | $33,460.00 | (11%) 103.66K to 92.39K | |
| 16-Nov-23 4:35 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Nov-23 | Sale | 3,036 | $2.97 | $9,016.92 | (3%) 89.29K to 86.26K | |
| 16-Nov-23 4:34 PM View: | Kohler Terry Chief Financial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Nov-23 | Sale | 9,632 | $2.97 | $28,607.00 | (22%) 44.05K to 34.42K | |
| 16-Nov-23 4:32 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 15-Nov-23 | Sale | 11,558 | $2.97 | $34,327.30 | (9%) 134.78K to 123.23K | |
| 16-Nov-23 4:35 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 14-Nov-23 | Sale | 5,817 | $2.93 | $17,043.80 | (6%) 95.11K to 89.29K | |
| 16-Nov-23 4:34 PM View: | Kohler Terry Chief Financial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 14-Nov-23 | Sale | 18,452 | $2.93 | $54,064.40 | (30%) 62.5K to 44.05K | |
| 16-Nov-23 4:32 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 14-Nov-23 | Sale | 22,141 | $2.93 | $64,873.10 | (14%) 156.93K to 134.78K | |
| 16-Nov-23 4:33 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 14-Nov-23 | Sale | 22,141 | $2.93 | $64,873.10 | (11%) 203.79K to 181.65K | |
| 16-Nov-23 4:49 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 14-Nov-23 | Sale | 21,580 | $2.93 | $63,229.40 | (17%) 125.24K to 103.66K | |
| 28-Aug-23 4:38 PM View: | Goldenberg Gary Chief Medical Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Aug-23 | Grant | 25,000 | -- | -- | 36% 70.11K to 95.11K | |
| 28-Aug-23 4:39 PM View: | Hayes Christopher G. Chief Legal Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Aug-23 | Grant | 75,000 | -- | -- | 92% 81.92K to 156.93K | |
| 28-Aug-23 4:40 PM View: | Kohler Terry Chief Financial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Aug-23 | Grant | 62,500 | -- | -- | 100% 0 to 62.5K | |
| 28-Aug-23 4:39 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 24-Aug-23 | Grant | 75,000 | -- | -- | 58% 128.79K to 203.79K | |
| 28-Aug-23 4:37 PM View: | Bonaccorso Joe Chief Commercial Officer | Verrica Pharmaceuticals Inc. (VRCA) | 24-Aug-23 | Grant | 62,500 | -- | -- | 100% 62.74K to 125.24K | |
| 25-Jul-23 4:18 PM View: | White Ted President and CEO Director | Verrica Pharmaceuticals Inc. (VRCA) | 24-Jul-23 | Sale | 50,677 | $4.83 | $244,770.00 | (28%) 179.47K to 128.79K |
